Neuropathic Pain and Type II Diabetic Patients
Diabetes Mellitus (DM) is a common metabolic disease characterized by hyperglycemia resulting from insufficiency, deficiency or absence of the insulin hormone. Chronic hyperglycemia, secondary metabolic and microvascular changes resulting in diabetic neuropathy are among the most common complications encountered in DM
| Condition(s) | Neuropathic Pain, Quality of Life, Diabetic Neuropathies |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Diabetes Mellitus (DM) is a common metabolic disease characterized by hyperglycemia resulting from insufficiency, deficiency or absence of the insulin hormone. Chronic hyperglycemia, secondary metabolic and microvascular changes resulting in diabetic neuropathy are among the most common complications encountered in DM patients. Diabetic neuropathy is called peripheral, autonomic or spinal depending on the region of involvement. Peripheral involvement is more common than other region involvement and its prevalence in DM patients is observed to be 16-87%. Diabetic peripheral neuropathy (DPN) presents with numbness, tingling, paresthesia, muscle weakness and pain. These symptoms can start from the toes and progress to the leg and even the upper extremities. In diabetic peripheral neuropathy, |
| Who can participate | Inclusion Criteria: * 18 years and older, * Diagnosed with type II diabetes, * Reading and writing, * No physical or psychological communication barriers, * Can read and speak Turkish, * Volunteers Exclusion Criteria: * Diagnosed with type I diabetes |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Lead sponsor | Bilecik Seyh Edebali Universitesi |
| Locations | Bilecik, Turkey (Türkiye) |
| Start date | 2024-12-15 |
| NCT ID | NCT06798181 |
| Official listing | https://clinicaltrials.gov/study/NCT06798181 |